Css LLC Incyte Corp Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $361,120 - $412,128	6,251 New	6,251 $361,000
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $2.2 Million - $2.67 Million	-26,436 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $542,648 - $676,280	-5,800 Reduced 17.99%	26,436 $2.5 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $3.52 Million - $4.46 Million	32,236	32,236 $3.76 Million

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.